Trial Profile
Rapid effect of Flutiform on pulmonary function compared with Relvar and Symbicort
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2019
Price :
$35
*
At a glance
- Drugs Formoterol/fluticasone propionate (Primary) ; Budesonide/formoterol; Vilanterol/fluticasone furoate
- Indications Asthma
- Focus Therapeutic Use
- 05 Mar 2018 Status changed from recruiting to completed.
- 09 Oct 2017 New trial record